Your browser doesn't support javascript.
loading
Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer.
Davis, Andrew A; Luo, Jingqin; Zheng, Tiantian; Dai, Chao; Dong, Xiaoxi; Tan, Lu; Suresh, Rama; Ademuyiwa, Foluso O; Rigden, Caron; Rearden, Timothy P; Clifton, Katherine; Weilbaecher, Katherine; Frith, Ashley; Tandra, Pavan K; Summa, Tracy; Haas, Brittney; Thomas, Shana; Hernandez-Aya, Leonel F; Peterson, Lindsay L; Wang, Xiaohong; Luo, Shujun J; Zhou, Kemin; Du, Pan; Jia, Shidong; King, Bonnie L; Krishnamurthy, Jairam; Ma, Cynthia X.
Afiliação
  • Davis AA; Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, Missouri.
  • Luo J; Division of Public Health Science, Department of Surgery, Biostatistics Shared Resource, Washington University in St. Louis, Missouri.
  • Zheng T; Predicine, Inc., Hayward, California.
  • Dai C; Predicine, Inc., Hayward, California.
  • Dong X; Predicine, Inc., Hayward, California.
  • Tan L; Predicine, Inc., Hayward, California.
  • Suresh R; Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, Missouri.
  • Ademuyiwa FO; Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, Missouri.
  • Rigden C; Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, Missouri.
  • Rearden TP; Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, Missouri.
  • Clifton K; Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, Missouri.
  • Weilbaecher K; Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, Missouri.
  • Frith A; Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, Missouri.
  • Tandra PK; Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, Nebraska.
  • Summa T; Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, Missouri.
  • Haas B; Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, Missouri.
  • Thomas S; Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, Missouri.
  • Hernandez-Aya LF; Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, Missouri.
  • Peterson LL; Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, Missouri.
  • Wang X; Predicine, Inc., Hayward, California.
  • Luo SJ; Predicine, Inc., Hayward, California.
  • Zhou K; Predicine, Inc., Hayward, California.
  • Du P; Predicine, Inc., Hayward, California.
  • Jia S; Predicine, Inc., Hayward, California.
  • King BL; Predicine, Inc., Hayward, California.
  • Krishnamurthy J; Division of Oncology/Hematology, University of Nebraska Medical Center, Omaha, Nebraska.
  • Ma CX; Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, Missouri.
Clin Cancer Res ; 29(9): 1719-1729, 2023 05 01.
Article em En | MEDLINE | ID: mdl-36693175
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article